logo
  • About us
    • In brief
    • The Board of Directors
    • Management Team
    • Corporate Governance
    • Intellectual Properties
    • Partnerships
    • Environment & quality
    • Organization
    • Career
  • Project portfolio
    • Project overview
    • Research areas
    • Development phases
    • Publications
  • Contract research
    • Autoradiography
    • Pharmacokinetics
    • Analytical chemistry
    • Disease models
  • Investor info
    • Contacts
    • Press releases
    • Stock
    • Interim reports
    • Annual reports
    • Presentations
    • Ownership
    • Official documents
    • Calendar
  • Press & news
    • Press releases
    • Interim reports
    • Annual reports
    • Features
    • Image bank
    • Calendar
    • Contacts
  • Contact
    • Visit us
rss RSS
font size decrease font increase font

Active Biotech develops innovative pharmaceuticals that modulate the body's own immune system.
We focus on widespread diseases for which a tremendous need is felt for new and more effective treatments.

  • 2013-06-12 TEVA AND ACTIVE BIOTECH REPORT POSITIVE RESULTS FROM PHASE IIa STUDY OF LAQUINIMOD IN ACTIVE LUPUS NEPHRITIS
  • 2013-06-03 Impact of Active Biotech's candidate drug tasquinimod on bone metastases presented at ASCO
  • 2013-06-03 Active Biotech's project ANYARA improved overall survival in a subgroup of renal cell cancer patients
  • 2013-05-30 Active Biotech to Present at the Jefferies 2013 Global Healthcare Conference
  • 2013-05-16 New data to be presented at the 2013 ASCO Annual Meeting show Active Biotech's commitment to oncology research

Active Biotech at the Jefferies 2013 Global Healthcare Conference

Listen to the presentation - June 4 at 4 pm EDT (10 pm CEST) >>

Tasquinimod presented at 2013 ASCO Annual Meeting

View the poster here >>

ANYARA presented at 2013 ASCO Annual Meeting

View the poster here >>

Annual General Meeting - May 15, 2013

Annual Report 2012

Subscribe to press releases from Active Biotech

Read more >>
Active Biotech AB, Scheelevägen 22, P.O. Box 724, SE-220 07 Lund, Sweden, Telephone +46 46 19 20 00